1448523-03-2

Upstream product

• 58635-45-3 methyl 2-(1-H-indol-3-yl)ethylcarbamate 
• 1344977-38-3 (-)-(3aS,3'aR,8aS,8'aS)-8'-allyl-7-bromo-1,1'-dimethyl-2,2',3,3',8,8a,8',8'a-octahydro-1H,1'H-3a,3'a-bipyrrolo[2,3-b]indole 
• 1448523-00-9 N-(2-(1-allyl-2-oxoindolin-3-yl)ethyl)-N,4-dimethylbenzenesulfonamide 
• 1448523-02-1 N-(2-(1-allyl-1H-indol-3-yl)ethyl)-N,4-dimethylbenzenesulfonamide 
• 442531-80-8 N-(2-(1H-indol-3-yl)ethyl)-N,4-dimethylbenzenesulfonamide 
• 98-59-9 p-toluenesulfonyl chloride 
• 61-49-4 [2-(1H-indol-3-yl)-ethyl]-methylamine 
• 4147-37-9 meso-Chimonanthine 
• 1344977-36-1 (-)-(3aS,3'aR,8aR,8'aS)-tert-butyl 8'-allyl-7-chloro-1,1'-dimethyl-2,2',3,3',8',8'ahexahydro-1H,1'H-[3a,3'a-bipyrrolo[2,3-b]indole]-8(8aH)-carboxylate 
• 1344977-44-1 (3aS,3'aR,8aR,8'aS)-8,8'-diallyl-1,1'-dimethyl-1,1',2,2',3,3a,3',3'a,8,8a,8',8'a-dodecahydro-3a,3'a-bipyrrolo[2,3-b]indole 
• 1344977-35-0 (-)-(3aR,3'aS,8aS,8'aS)-8-allyl-1,1'-dimethyl-1,1',2,2',3,3a,3',3'a,8,8a,8',8'a-dodecahydro-3a,3'a-bipyrrolo[2,3-b]indole 
• 1344977-37-2 (-)-(3aS,3'aR,8aR,8'aS)-tert-butyl 8'-allyl-7-bromo-1,1'-dimethyl-2,2',3,3',8',8'ahexahydro-1H,1'H-3a,3'a-bipyrrolo[2,3-b]indole-8(8aH)-carboxylate 

Relevant academic research and scientific papers

Catalytic enantioselective desymmetrisation as a tool for the synthesis of hodgkinsine and hodgkinsine B

Two palladium-catalysed amination protocols are deployed in the desymmetrisation of the complex dimeric alkaloid meso-chimonanthine. The power of these transformations is showcased in an efficient formal and total synthesis of the natural products hodgkinsine and hodgkinsine B, respectively. Two palladium-catalysed amination protocols are deployed in the desymmetrisation of the complex dimeric alkaloid meso-chimonanthine. The power of these transformations is showcased in efficient formal and total synthesis of the natural products hodgkinsine and hodgkinsine B (see figure), respectively. Copyright